￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

Oncology

The response rate of mobotinib, a drug targeting EGFR gene mutation in non-small cell lung cancer, reaches 43%_ Kanghule

2025-10-19 11:44:20

Check Details
Is Mobotinib on the market? Is there a place to sell it in Wuhan?

2025-10-19 11:44:20

Check Details
The anti-tumor drug Pozitinib has a lung cancer disease response rate of up to 90%

2025-10-19 11:44:20

Check Details
What conditions does larotrectinib mainly treat? Is the treatment effective

2025-10-19 11:44:20

Check Details
Will larotrectinib develop resistance? What should you pay attention to when using it

2025-10-19 11:44:20

Check Details
What drug is tepotinib? Is it effective?

2025-10-19 11:44:20

Check Details
【Drug Information】Take you into Tepotinib

2025-10-19 11:44:20

Check Details
LUMYKRAS receives positive opinion from CHMP for the treatment of patients with KRAS G12C mutated advanced NSCLC_ Kanghule

2025-10-19 11:44:20

Check Details
MET inhibitor-capmatinib_Kangxule

2025-10-19 11:44:20

Check Details
Where can I buy capmatinib in Inner Mongolia? Can I use medical insurance?

2025-10-19 11:44:20

Check Details
How long does it take for resistance to icotinib to develop? How long can one live after icotinib is used to treat advanced lung cancer?

2025-10-19 11:44:20

Check Details
Today is International Lung Cancer Day. How much do you know about lung cancer?

2025-10-19 11:44:20

Check Details
Category
相关知识